Javascript must be enabled to continue!
Regulation of Na+-K+-Cl−cotransporter in primary astrocytes by dibutyryl cAMP and high [K+]o
View through CrossRef
In this study, we examined the Na+-K+-Cl− cotransporter activity and expression in rat cortical astrocyte differentiation. Astrocyte differentiation was induced by dibutyryl cAMP (DBcAMP, 0.25 mM) for 7 days, and cells changed from a polygonal to process-bearing morphology. Basal activity of the cotransporter was significantly increased in DBcAMP-treated astrocytes ( P < 0.05). Expression of an ∼161-kDa cotransporter protein was increased by 91% in the DBcAMP-treated astrocytes. Moreover, the specific [3H]bumetanide binding was increased by 67% in the DBcAMP-treated astrocytes. Inhibition of protein synthesis by cyclohexamide (2–3 μg/ml) significantly attenuated the DBcAMP-mediated upregulation of the cotransporter activity and expression. The Na+-K+-Cl−cotransporter in astrocytes has been suggested to play a role in K+ uptake. In 75 mM extracellular K+concentration, the cotransporter-mediated K+ influx was stimulated by 147% in nontreated cells and 79% in DBcAMP-treated cells ( P < 0.05). To study whether this high K+-induced stimulation of the cotransporter is attributed to membrane depolarization and Ca2+ influx, the role of the L-type voltage-dependent Ca2+ channel was investigated. The high-K+-mediated stimulation of the cotransporter activity was abolished in the presence of either 0.5 or 1.0 μM of the L-type channel blocker nifedipine or Ca2+-free HEPES buffer. A rise in intracellular free Ca2+ in astrocytes was observed in high K+. These results provide the first evidence that the Na+-K+-Cl− cotransporter protein expression can be regulated selectively when intracellular cAMP is elevated. The study also demonstrates that the cotransporter in astrocytes is stimulated by high K+ in a Ca2+-dependent manner.
American Physiological Society
Title: Regulation of Na+-K+-Cl−cotransporter in primary astrocytes by dibutyryl cAMP and high [K+]o
Description:
In this study, we examined the Na+-K+-Cl− cotransporter activity and expression in rat cortical astrocyte differentiation.
Astrocyte differentiation was induced by dibutyryl cAMP (DBcAMP, 0.
25 mM) for 7 days, and cells changed from a polygonal to process-bearing morphology.
Basal activity of the cotransporter was significantly increased in DBcAMP-treated astrocytes ( P < 0.
05).
Expression of an ∼161-kDa cotransporter protein was increased by 91% in the DBcAMP-treated astrocytes.
Moreover, the specific [3H]bumetanide binding was increased by 67% in the DBcAMP-treated astrocytes.
Inhibition of protein synthesis by cyclohexamide (2–3 μg/ml) significantly attenuated the DBcAMP-mediated upregulation of the cotransporter activity and expression.
The Na+-K+-Cl−cotransporter in astrocytes has been suggested to play a role in K+ uptake.
In 75 mM extracellular K+concentration, the cotransporter-mediated K+ influx was stimulated by 147% in nontreated cells and 79% in DBcAMP-treated cells ( P < 0.
05).
To study whether this high K+-induced stimulation of the cotransporter is attributed to membrane depolarization and Ca2+ influx, the role of the L-type voltage-dependent Ca2+ channel was investigated.
The high-K+-mediated stimulation of the cotransporter activity was abolished in the presence of either 0.
5 or 1.
0 μM of the L-type channel blocker nifedipine or Ca2+-free HEPES buffer.
A rise in intracellular free Ca2+ in astrocytes was observed in high K+.
These results provide the first evidence that the Na+-K+-Cl− cotransporter protein expression can be regulated selectively when intracellular cAMP is elevated.
The study also demonstrates that the cotransporter in astrocytes is stimulated by high K+ in a Ca2+-dependent manner.
Related Results
Astrocytes improve neuronal health after cisplatin treatment through mitochondrial transfer
Astrocytes improve neuronal health after cisplatin treatment through mitochondrial transfer
AbstractNeurodegenerative disorders, including chemotherapy-induced cognitive impairment, are associated with neuronal mitochondrial dysfunction. Cisplatin, a commonly used chemoth...
The Automedial Zaniness of Ryan Trecartin
The Automedial Zaniness of Ryan Trecartin
IntroductionThe American artist Ryan Trecartin makes digital videos that centre on the self-presentations common to video-sharing sites such as YouTube. Named by New Yorker critic ...
Sodium-Glucose Cotransporter-2 Inhibitors in Odontogenic Infections
Sodium-Glucose Cotransporter-2 Inhibitors in Odontogenic Infections
On top of improving glycemic control, sodium-glucose cotransporter-2 inhibitors have been shown to reduce cardiovascular mortality & heart failure hospitalization. Sodium-gluco...
Sodium-Glucose Cotransporter-2 Inhibitors In Odontogenic Infections
Sodium-Glucose Cotransporter-2 Inhibitors In Odontogenic Infections
Abstract
On top of improving glycemic control, sodium-glucose cotransporter-2 inhibitors have been shown to reduce cardiovascular mortality & heart failure hospitalizat...
Dysregulation of Ca2+ signaling in astrocytes from mice lacking amyloid precursor protein
Dysregulation of Ca2+ signaling in astrocytes from mice lacking amyloid precursor protein
The relationship between altered metabolism of the amyloid-β precursor protein (APP) and Alzheimer's disease is well established but the physiological roles of APP still remain unc...
Basolateral amygdala astrocytes modulate of diabetic neuropathic pain and may be a potential therapeutic target for koumine
Basolateral amygdala astrocytes modulate of diabetic neuropathic pain and may be a potential therapeutic target for koumine
Background and Purpose: New remedies are required for the treatment of
diabetic neuropathic pain (DNP) due to insufficient efficacy of
available therapies. Here, we used chemogenet...
THE SONIC HEDGEHOG AGONIST SAG ATTENUATES MITOCHONDRIAL DYSFUNCTION AND DECREASES THE NEUROTOXOCITY INDUCED BY FRATAXIN-DEFICIENT ASTROCYTES
THE SONIC HEDGEHOG AGONIST SAG ATTENUATES MITOCHONDRIAL DYSFUNCTION AND DECREASES THE NEUROTOXOCITY INDUCED BY FRATAXIN-DEFICIENT ASTROCYTES
Friedreich’s ataxia (FRDA) is predominantly a neurodegenerative disease caused by the deficiency of a protein called frataxin (FXN). Although the main pathological alterations are ...
Spatial And Functional Coupling of The L‐Type Ca2+ Channel Cav1.2 with Ca2+‐Induced Ca2+ Release And cAMP Accumulation in INS‐1 cells
Spatial And Functional Coupling of The L‐Type Ca2+ Channel Cav1.2 with Ca2+‐Induced Ca2+ Release And cAMP Accumulation in INS‐1 cells
Exposure of pancreatic β‐cells to glucose generates concomitant oscillations in Ca2+ and cAMP which regulate insulin secretion, an essential function of β‐cells that promotes gluco...


